The Pontifical Catholic University of Paraná is a private, not-for-profit Catholic university. The main campus is located in Curitiba, the capital city of the State of Paraná, Brazil. There are four additional campuses located in the cities of Londrina, Maringá, São José dos Pinhais and Toledo.

During the past decade, Pontifícia Universidade Católica do Paraná conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pontifícia Universidade Católica do Paraná" #1 sponsor was "Alexandra Cristina Senegaglia" with 1 trials, followed by "Hospital Israelita Albert Einstein" with 1 trials sponsored, "Hospital de Clinicas de Porto Alegre" with 1 trials sponsored, "Pontifícia Universidade Católica do Paraná" with 1 trials sponsored and "University of Manitoba" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pontifícia Universidade Católica do Paraná" #1 collaborator was "Fundação Araucária" with 2 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 1 trials as a collaborator, "Hospital Geral Nacional Enrique Cabrera, Cuba" with 1 trials as a collaborator, "Hospital Sao Rafael" with 1 trials as a collaborator and "Instituto de Hematología e Inmunología, Cuba" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Pontifícia Universidade Católica do Paraná" are "Acute Coronary Syndrome" (1 trials), "COVID-19" (1 trials), "Diabetic Foot" (1 trials), "Gangrene" (1 trials) and "Ischemic Cardiomyopathy" (1 trials). Many other conditions were trialed in "Pontifícia Universidade Católica do Paraná" in a lesser frequency.

Most popular intervention types in "Pontifícia Universidade Católica do Paraná" are "Procedure" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Antiplatelet Monotherapy" (1 trials), "BM-MNC injection" (1 trials), "Bronchoscopy" (1 trials), "Heparin" (1 trials) and "MSCs injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pontifícia Universidade Católica do Paraná" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Pontifícia Universidade Católica do Paraná". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Pontifícia Universidade Católica do Paraná, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pontifícia Universidade Católica do Paraná, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".